Pediheart Podcast #361: Can The Adult Fontan Patient Medication List Offer Clues Into Long-Term Outcomes?

This week we speak with Ohio State ACHD fellow Andrew Freddo MD, PhD about a recent large single center study he conducted assessing the cardiovascular drugs that adult Fontan patients are taking and whether they might offer us insights into general well-being. Are there agents that are associated with worse outcomes? If so, is this a situation of the agent causing harm or is it a possible marker of illness? Are there agents associated with improved outcomes? These are amongst the questions reviewed with Dr. Freddo this week. <br /><br /><ul><li>DOI: <a href="https://doi.org/10.1016/j.jacadv.2025.102070" target="_blank" rel="noreferrer noopener">10.1016/j.jacadv.2025.102070</a></li></ul>